GSK
GlaxoSmithKline PLC ADRNYSEHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$112.27B
P/E Ratio
15.26
EPS
$3.66
Beta
0.35
52W High
$61.21
52W Low
$31.47
50-Day MA
$55.63
200-Day MA
$46.33
Dividend Yield
3.18%
Profit Margin
17.50%
Forward P/E
22.42
PEG Ratio
0.50
About GlaxoSmithKline PLC ADR
GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines, over-the-counter drugs and health-related consumer products in the UK, US and internationally. The company is headquartered in Brentford, the United Kingdom.
Fundamentals
| Revenue (TTM) | $32.67B |
| Gross Profit (TTM) | $23.72B |
| EBITDA | $11.34B |
| Operating Margin | 18.90% |
| Return on Equity | 43.30% |
| Return on Assets | 9.79% |
| Revenue/Share (TTM) | $16.13 |
| Book Value | $5.40 |
| Price-to-Book | 5.22 |
| Price-to-Sales (TTM) | 3.44 |
| EV/Revenue | 3.069 |
| EV/EBITDA | 9.64 |
| Quarterly Earnings Growth (YoY) | 54.70% |
| Quarterly Revenue Growth (YoY) | 6.20% |
| Shares Outstanding | $2.00B |
| Float | $3.88B |
| % Insiders | 0.06% |
| % Institutions | 19.81% |
Analyst Ratings
Consensus ($57.48 target)
1
Buy6
Hold1
SellData last updated: 4/8/2026